The expression of cyclooxygenase in transitional cell carcinoma cell lines: Its correlation with tumor differentiation, invasiveness and prostanoids production

European Urology

Volumn 44, Issue 4, 2003, Pages 491-494

  Yu, Dah Shyong ^a   Chen, Hong I ^a   Chang, Sun Yran ^a  

^a NATIONAL DEFENSE UNIVERSITY   (Taiwan)

Author keywords

Cyclooxygenase; Prostaglandin; Transitional cell carcinoma; Tumor differentiation; Tumor invasiveness

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; MESSENGER RNA; PROSTAGLANDIN E2; PROSTANOID; THROMBOXANE B2;

ARTICLE; BLADDER CARCINOGENESIS; CANCER CELL; CANCER CELL CULTURE; CANCER GRADING; CANCER GROWTH; CANCER INVASION; CELL DIFFERENTIATION; CELL STRAIN; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; CYTOPLASM; DISEASE ACTIVITY; HUMAN; HUMAN CELL; MALE; PARAMETER; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSITIONAL CELL CARCINOMA; WESTERN BLOTTING;

EID: 0141683571     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0302-2838(03)00311-7     Document Type: Article

References (19)

1. Marnett L. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 1992;52:5575-89.
2. Bronstein J, Bull A. The correlation between 13-hydroxyoctadecadienoate dehydrogenase (13-HODE dehydrogenase) and intestinal cell differentiation. Prostaglandin 1993;46:387-95.
3. Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB. Arachidonic acid metabolism. Annu Rev Biochem 1986;55:69-102.
4. Sheng H, Shoa J, Morrow JD, Beauchamp RD, DuBois RN. Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 1998;58:362-6.
5. Tjandrawinata RR, Dahiya R, Hughes-Fulford M. Induction of cyclooxygenase-2 mRNA by prostaglandin E2 in human prostatic carcinoma cells. Br J Cancer 1997;75:1111-8.
6. Uotila P. Inhibition on prostaglandin E2 formation and histamine action in cancer immunotherapy. Cancer Immunol Immunother 1993; 37:251-4.
7. Tsuji M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois R. Cyclooxygenase regulates angiogensis induced by colon cancer cells. Cell 1998;93:705-16.
8. Moon RC, Kelloff GJ, Detrisac CJ, Steele VE, Thomas CF, Sigman CC. Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam. Carcinogensis (Lond) 1993;14:1487-9.
9. Knapp DW, Richardson RC, Chan TC, Bottoms GD, Widmer WR, DeNicola DB, et al. Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med 1994;8:273-8.
10. Mohammed SI, Knapp DW, Bostwick DG, Foster RS, Khan KNM, Masferrer JL, et al. Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder. Cancer Res 1999;59:5647-50.
11. Urinary bladder. In: Fleming ID, Cooper JS, Henson DE, editors. AJCC cancer staging manual. Philadelphia: Lippincott-Raven; 1997. p. 241-3.
12. Epstein JI, Amin MD, Renta VR. The World Health Organization/ International Society of Urological Pathology Consensus Classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am J Surg Pathol 1998;22:1435-48.
13. Long JP, Prout GR, Wong YK. The effect of verapamil on a multidrug resistant bladder carcinoma cell line and its potential as on intravesical chemotherapeutic agent. J Urol 1990;143:1053-6.
14. Rigby PWJ, Dieckmann M, Rhodes C, Berg P. Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I. J Biol Chem 1977;113:237-51.
15. Thomas PS. Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 1980;77:5201-5.
16. Cummings KB. Carcinoma of the bladder: predictors. Cancer (Phila) 1980;45:1849-55.
17. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998;58:4997-5001.
18. Koga H, Sakisaka S, Ohishi M, Kawaguchi T, Taniguchi E, Sasatomi K, et al. Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation. Hepatol 1999;29:688-96.
19. Shariat SF, Kim J-H, Ayala GE, Kho K, Wheelers TM, Lerner SP. Cyclooxygenase-2 is highly expressed in carcinoma in situ and T1 transitional cell carcinoma of the bladder. J Urol 2003;169: 938-42.